At the end of the day, biotech venture capital is a business and driving returns is the ultimate metric. For twenty years, to deliver on that, I’ve embraced what I call the “first principle” of early stage biotech investing: if The post Twenty Years In Early Stage Biotech VC (Part 3): Business appeared first on LifeSciVC.
